Continuation vehicle fund research profile
Samara Capital Continuation Fund is a single continuation vehicle formed around three Samara Fund II assets: Sahajanand Medical Technologies, First Meridian Business Services and Paradise Food Court. It is useful for comparing concentrated continuation structures with Samara’s newer India Fund III activity, which is deliberately kept separate here.
At a glance
Research profile
Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.
Investment lens
Samara Capital Continuation Fund uses a continuation vehicle; mid-market buyout and growth private equity approach across Healthcare, consumer, business services.
Current evidence
Samara’s 2025 public update described Fund II’s wind-down and continuation structure, while independent transaction research identifies the three assets transferred to the January 2023 consortium. Samara’s separate Fund III disclosures are retained only as manager context.
Strategy
Continuation vehicle; mid-market buyout and growth private equity
Sector focus
Healthcare, consumer, business services
AIF structure context
Indian private equity, growth, buyout and many real-asset strategies are commonly structured as Category II AIFs. Verify the specific vehicle and registration before investing.
Current signal
Samara’s 2025 public update described Fund II’s wind-down and continuation structure, while independent transaction research identifies the three assets transferred to the January 2023 consortium. Samara’s separate Fund III disclosures are retained only as manager context.
Investor questions
Samara Capital Continuation Fund is covered in Rupeia's private equity research universe. The current public record describes the strategy as Continuation vehicle; mid-market buyout and growth private equity, with a sector focus of Healthcare, consumer, business services. The profile should be read with the linked source trail and Typical route: Category II AIF context.
The profile displays only company or asset names attributable to Samara Capital Continuation Fund in the reviewed public sources: Sahajanand Medical Technologies; First Meridian Business Services; Paradise Food Court. It does not represent a complete current portfolio unless the manager has published one.
The January 2023 transaction created liquidity for Samara Fund II while retaining exposure to three named businesses. Samara later reported that Fund II was winding down in 2025; continuation-vehicle IRR, DPI and TVPI are not publicly disclosed. These signals are not a substitute for fund- and vintage-specific net performance, realised distributions and audited or administrator-supported reporting.
Public fund size: Not publicly disclosed. Public transaction materials identify the continuation structure and institutional backers but not a final vehicle corpus.. Public terms or access information: Continuation vehicle holding interests in three disclosed Samara Fund II assets; fees, carry, waterfall, term and reinvestment rights are not publicly disclosed.. Current fees, minimum commitment and availability must be confirmed for the exact named vehicle in its fund documents.
The current source record names Sumeet Narang (Founder and Managing Partner); Samara Capital investment team. Verify current roles, departures, attribution and key-person provisions before relying on the team history for a new commitment.
Review entry valuation, leverage, governance rights, concentration, execution of the value-creation plan and exit timing. The current open diligence point is: The formal legal vehicle name, final commitment amount, ownership percentages, fees, carry, term and audited vehicle-level returns are not publicly disclosed. The descriptive title is used because public sources identify a Samara continuation vehicle but not a separately branded fund name..
2025-06-26: Samara’s 2025 public update described Fund II’s wind-down and continuation structure, while independent transaction research identifies the three assets transferred to the January 2023 consortium. Samara’s separate Fund III disclosures are retained only as manager context.
Next step
Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.